Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0360
-0.0040 (-10.00%)
Apr 28, 2026, 1:54 PM EST
Oncotelic Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
26
Market Cap
15.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zeo ScientifiX | 5.56M |
| HOOKIPA Pharma | 9.35M |
| Provectus Biopharmaceuticals | 336.11K |
| Arch Biopartners | 115.29K |
| Harvard Apparatus Regenerative Technology | 704.00K |
Oncotelic Therapeutics News
- 4 days ago - NetworkNews Audio Announces Audio Press Release (APR) Discussing Advancing Oncology Therapeutics, Strategic Positioning within High-Value Development Pathways - GlobeNewsWire
- 4 days ago - Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy - GlobeNewsWire
- 5 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation - GlobeNewsWire
- 7 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution - GlobeNewsWire
- 12 days ago - Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress - GlobeNewsWire
- 18 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space - GlobeNewsWire
- 20 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies, - GlobeNewsWire
- 5 weeks ago - Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026 - GlobeNewsWire